Stockscreener 앱 받기
0.00
100.00%
-0.2075
Casi Pharmaceuticals Inc 주식(CASI)의 최신 뉴스
Short Squeeze: Can CASI Pharmaceuticals Inc deliver consistent EPS growth2025 Valuation Update & Daily Stock Momentum Reports - baoquankhu1.vn
CASI Pharmaceuticals Inc. (CASIF) Price To Cash Flow - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Total Liabilities - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Return On Equity (TTM) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Total Long Term Debt (Quarterly) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Enterprise Value - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Total Expenses (Quarterly) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Book Value - Zacks Investment Research
CASI PHARMACEUTICALS INC (CASIF.US) Income Statements, Balance Sheet & Cashflow - Longbridge
CASI PHARMACEUTICALS INC (CASIF.US) Latest News & Headlines - Longbridge
CASI Pharmaceuticals, Inc.: Financial Data Forecasts Estimates and Expectations | CASIF | KYG1933S1012 - marketscreener.com
CASI Pharmaceuticals, Inc.: Target Price Consensus and Analysts Recommendations | CASIF | KYG1933S1012 - marketscreener.com
CASI Pharmaceuticals, Inc.: Revenue and Earnings Analysts Forecasts Revisions | CASIF | KYG1933S1012 - marketscreener.com
Casi Pharmaceuticals CEO David Cory to step down at end of March - Investing.com
CASI Pharmaceuticals CEO David Cory to Step Down; Executive Chairman Wei-Wu He Assumes Top Role - TipRanks
Leadership change at CASI Pharmaceuticals (NASDAQ: CASI) as CEO exits - Stock Titan
CASI Pharmaceuticals Inc. (CASIF) Gross Margin (TTM) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Debt Equity Ratio (Quarterly) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Price Book Value - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Cash From Operations (TTM) - Zacks Investment Research
CASIF (CASI Pharmaceuticals) PB Ratio : (As of Mar. 02, 2026) - GuruFocus
CASI Pharmaceuticals Inc. (CASIF) Return On Assets (TTM) - Zacks Investment Research
Net debt of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
CASI Pharmaceuticals Inc. (CASIF) Earnings Yield (TTM) - Zacks Investment Research
EBIT per share of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
EBITDA margin % of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
After tax other income/expense of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
Long term debt to total equity ratio of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
Operating expenses (excl. COGS) of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
CapEx per share of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
Net current asset value per share of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
Preferred dividends of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
Enterprise value to EBITDA ratio of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
Working capital per share of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
Total debt of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
Free cash flow per share of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
Total debt per share of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
CASI Pharmaceuticals, Inc. Balance Sheet – OTC:CASIF - TradingView
Technical Analysis of CASI Pharmaceuticals, Inc. (OTC:CASIF) - TradingView
CASI Pharmaceuticals Inc. (CASIF) Revenue (Quarterly) Yoy Growth - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Total Expenses (TTM) - Zacks Investment Research
Diluted shares outstanding of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
Gross profit of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
EBIT of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
Dilution adjustment of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
Non-controlling/minority interest of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
Free cash flow of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
CASI Pharmaceuticals, Inc. Statistics – OTC:CASIF - TradingView
EBITDA of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
Pretax income of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
CASI Pharmaceuticals, Inc. Cash Flow – OTC:CASIF - TradingView
Total revenue of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
Taxes of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
Total operating expenses of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
Operating income of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
CASI Pharmaceuticals Inc. (CASIF) Revenue (TTM) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Cash From Operations (Quarterly) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Net Income (Quarterly) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Gross Profit (TTM) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Revenue (Quarterly) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Cash From Financing (Quarterly) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Free Cash Flow (Quarterly) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Total Assets (Quarterly) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Price - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Book Value (Per Share) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Cash Equivalents (Quarterly) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Price To Free Cash Flow - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Dividend Yield (TTM) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Net Income (TTM) - Zacks Investment Research
CASI Pharmaceuticals Inc. (CASIF) Dividend (TTM) - Zacks Investment Research
CASIF: CASI Pharmaceuticals Inc.12 Month EPS - Zacks Investment Research
1.57%
0.40%
자본화:
|
볼륨(24시간):